SG Americas Securities’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.72M Buy
77,208
+35,243
+84% +$842K ﹤0.01% 1464
2025
Q4
$1.12M Buy
41,965
+2,285
+6% +$54.6K ﹤0.01% 1918
2025
Q3
$847K Buy
39,680
+34,118
+613% +$807K ﹤0.01% 1627
2025
Q2
$120K Sell
5,562
-12,588
-69% -$234K ﹤0.01% 2557
2025
Q1
$301K Sell
18,150
-2,465,581
-99% -$44.8M ﹤0.01% 2202
2024
Q4
$45.6M Buy
2,483,731
+1,966,607
+380% +$31.7M 0.2% 59
2024
Q3
$7.95M Buy
517,124
+417,648
+420% +$6.97M 0.03% 308
2024
Q2
$1.62M Buy
99,476
+14,520
+17% +$234K 0.01% 1064
2024
Q1
$1.57M Buy
84,956
+60,452
+247% +$1.5M 0.01% 966
2023
Q4
$767K Sell
24,504
-47,951
-66% -$1.15M 0.01% 1189
2023
Q3
$1.51M Buy
72,455
+67,222
+1,285% +$1.83M 0.02% 933
2023
Q2
$125K Sell
5,233
-146,745
-97% -$3.26M ﹤0.01% 1999
2023
Q1
$2.86M Buy
151,978
+137,924
+981% +$2.63M 0.04% 486
2022
Q4
$224K Sell
14,054
-9,891
-41% -$155K ﹤0.01% 2116
2022
Q3
$392K Sell
23,945
-47,554
-67% -$770K 0.01% 1763
2022
Q2
$1.01M Buy
71,499
+65,003
+1,001% +$1.21M 0.01% 1294
2022
Q1
$157K Sell
6,496
-18,623
-74% -$451K ﹤0.01% 2555
2021
Q4
$586K Sell
25,119
-36,536
-59% -$735K ﹤0.01% 2060
2021
Q3
$1.02M Buy
61,655
+46,947
+319% +$905K 0.01% 1890
2021
Q2
$359K Buy
14,708
+7,024
+91% +$159K ﹤0.01% 2091
2021
Q1
$198K Buy
7,684
+2,646
+53% +$116K ﹤0.01% 2684
2020
Q4
$269K Sell
5,038
-3,447
-41% -$171K ﹤0.01% 2443
2020
Q3
$350K Buy
8,485
+317
+4% +$13.7K ﹤0.01% 1846
2020
Q2
$396K Sell
8,168
-19,405
-70% -$932K ﹤0.01% 2295
2020
Q1
$1.17M Buy
27,573
+6,189
+29% +$255K 0.02% 1188
2019
Q4
$915K Sell
21,384
-1,123
-5% -$48.9K 0.01% 1324
2019
Q3
$810K Buy
22,507
+15,183
+207% +$460K 0.01% 1546
2019
Q2
$196K Sell
7,324
-3,226
-31% -$82.4K ﹤0.01% 2418
2019
Q1
$283K Sell
10,550
-5,171
-33% -$121K ﹤0.01% 2313
2018
Q4
$254K Buy
15,721
+1,750
+13% +$34K ﹤0.01% 2270
2018
Q3
$290K Buy
13,971
+4,498
+47% +$70.8K ﹤0.01% 2385
2018
Q2
$145K Sell
9,473
-19,706
-68% -$351K ﹤0.01% 2826
2018
Q1
$656K Sell
29,179
-34,755
-54% -$962K 0.01% 1693
2017
Q4
$1.93M Buy
63,934
+59,588
+1,371% +$1.91M 0.02% 921
2017
Q3
$164K Sell
4,346
-2,889
-40% -$94K ﹤0.01% 2759
2017
Q2
$202K Sell
7,235
-4,014
-36% -$120K ﹤0.01% 2420
2017
Q1
$387K Sell
11,249
-55,555
-83% -$1.96M ﹤0.01% 2017
2016
Q4
$1.93M Buy
66,804
+53,727
+411% +$1.42M 0.02% 927
2016
Q3
$416K Buy
13,077
+575
+5% +$19.5K ﹤0.01% 1881
2016
Q2
$406K Buy
12,502
+1,214
+11% +$40.6K ﹤0.01% 1820
2016
Q1
$316K Buy
11,288
+1,681
+17% +$36.7K ﹤0.01% 1972
2015
Q4
$342K Sell
9,607
-8,526
-47% -$300K ﹤0.01% 1840
2015
Q3
$600K Buy
18,133
+12,905
+247% +$537K ﹤0.01% 1012
2015
Q2
$219K Sell
5,228
-4,592
-47% -$178K ﹤0.01% 1945
2015
Q1
$320K Sell
9,820
-16,146
-62% -$555K ﹤0.01% 1652
2014
Q4
$824K Buy
25,966
+11,296
+77% +$320K ﹤0.01% 1328
2014
Q3
$363K Buy
14,670
+4,352
+42% +$102K ﹤0.01% 1635
2014
Q2
$233K Buy
10,318
+5,318
+106% +$111K ﹤0.01% 1969
2014
Q1
$122K Buy
+5,000
New +$126K ﹤0.01% 2149
2013
Q4
Sell
-14,440
Closed -$397K 2622
2013
Q3
$397K Buy
+14,440
New +$302K ﹤0.01% 1745

Other funds holding ACAD